Status:
COMPLETED
Applying mHealth to Tobacco-related Health Disparities
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborating Sponsors:
National Institute on Minority Health and Health Disparities (NIMHD)
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study is to better understand what happens when someone attempts to quit smoking.
Detailed Description
Investigators will provide participants with nicotine patches, smoking cessation treatment that will include brief counseling sessions (10-15 minutes each), and text messages sent to their provided st...
Eligibility Criteria
Inclusion
- Smoked a minimum of 3 cigarettes per day over the past year
- Expired carbon monoxide reading ≥ 6
- Motivated to quit within the next 30 days
- Valid home address
- Functioning telephone number
- Can speak, read, and write in English
- At least marginal health literacy
Exclusion
- Contraindication for the nicotine patch (e.g., heart attack, angina, skin allergies) unless a doctor's note is provided
- Endorse current psychosis
- Have a pacemaker or implanted device
- Physically unable to wear equipment and provide a good reading of physiological measures
- Current use of tobacco cessation medications
- Current use of of smoking products other than cigarettes and e-cigarettes
- Involvement in a smoking program or currently trying to quit
- Pregnancy or lactation
- Another household member being enrolled in the study
- No prior experience with a smart phone
- The study staff or principal investigator (PI) have serious concerns about the participant's ability to engage in and/or complete the study protocol.
Key Trial Info
Start Date :
July 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 14 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03404596
Start Date
July 16 2018
End Date
December 14 2020
Last Update
May 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States, 33612